DexCom
DXCM
732 hedge funds and large institutions have $33.9B invested in DexCom in 2020 Q4 according to their latest regulatory filings, with 118 funds opening new positions, 294 increasing their positions, 247 reducing their positions, and 106 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 294 | Existing positions reduced: 247
11% more first-time investments, than exits
New positions opened: 118 | Existing positions closed: 106
1% more funds holding
Funds holding: 727 → 732 (+5)
5.31% less ownership
Funds ownership: 384.45% → 379.15% (-5.3%)
10% less capital invested
Capital invested by funds: $37.8B → $33.9B (-$3.91B)
15% less call options, than puts
Call options by funds: $555M | Put options by funds: $654M
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$568M |
| 2 |
Morgan Stanley
New York
|
-$361M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$344M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$278M |
| 5 |
Goldman Sachs
New York
|
-$269M |
DXCM Hedge Fund Activity: Q4 2020 in Review
732 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2020, worth a combined $33.9B — down 10% from $37.8B a quarter earlier.
Buyers outnumbered sellers: 118 funds opened new DXCM positions and 106 closed out — a net gain of 12 holders — while 294 added to existing stakes and 247 trimmed.
The largest buyer was Lone Pine Capital, adding an estimated $645M. The largest seller was Fidelity Investments, cutting an estimated $568M.
- 732 institutional investors held DexCom (DXCM) as of Q4 2020, up from 727 in Q3 2020.
- Funds reported $33.9B of DexCom stock for Q4 2020, down 10% quarter-over-quarter.
- 118 funds opened new DexCom positions in Q4 2020 and 106 closed out, a net change of +12 holders.
- The largest DexCom buyer in Q4 2020 was Lone Pine Capital, an estimated $645M added.
- The largest DexCom seller in Q4 2020 was Fidelity Investments, an estimated $568M sold.
Based on aggregated 13F filings for Q4 2020.